The Pharmacy Compounding Advisory Committee (PCAC) met on 23 and 24 July 2026 to consider seven peptides for inclusion on the Section 503A Bulk Drug Substances List
GLP3 peptide was engineered from a GIP peptide backbone to simultaneously activate GLP-1, GIP, and glucagon receptors, while Cagrilintide peptide is a modified amylin analog designed with enhanced stability to resist the fibrillation that makes native amylin challenging to work with
C.HuangS
Pizzorno, Joseph E
Most patients using GHK-Cu at our Doral clinic are also on NAD+ because the two serve the same demographic: people investing in long-term health optimization
You have a BMI in a range where medical weight-loss treatment may be appropriate You have weight-related health risks such as high blood pressure, prediabetes, diabetes, sleep apnea, or high cholesterol You want provider monitoring instead of a one-time online order You are ready for follow-up visits, nutrition changes, and long-term planning Pricing and insurance transparency Coverage varies by medication, diagnosis, insurance plan, and pharmacy benefit
